IRIS-PREMIER REGISTRY

NCT02060968 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2006

Last updated 2021-09-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate effectiveness and safety of Promus PREMIER in Routine Clinical Practice

Conditions

Interventions

DEVICE

Promus PREMIER

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER
  • Boston Scientific Korea Co. Ltd

    collaborator INDUSTRY
  • Seung-Jung Park

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-06-30
Completion
2021-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02060968 on ClinicalTrials.gov